Literature DB >> 25300787

A search for functional histamine H4 receptors in the human, guinea pig and mouse brain.

Monika Feliszek1, Valerie Speckmann, Daniel Schacht, Marec von Lehe, Holger Stark, Eberhard Schlicker.   

Abstract

Histamine H4 receptors are expressed in immune cells, but their potential role in the brain is less clear. Although H4 transcripts have been identified in human and rat brain, the presence of H4 receptors on the protein level has so far not been proven since appropriate antibodies fulfilling the strict criteria for G protein-coupled receptors are missing. Here, we searched for functional H4 receptors in human, guinea pig and mouse cortex. We studied whether H4 receptor activation is associated with increased GTPγS binding and reduced noradrenaline release. The latter two effects have been previously shown for H3 receptors, which, like the H4 receptors, are coupled to G i/o protein. G protein activation was studied using (35)S-GTPγS binding in cortical membranes. The electrically induced (3)H-noradrenaline release was determined in superfused cortical slices. The H4 agonist 4-methylhistamine failed to affect (35)S-GTPγS binding and/or noradrenaline release in human, guinea pig and mouse cortex although an H 3 receptor-mediated increase in (35)S-GTPγS binding and inhibition of noradrenaline release occurred in parallel experiments. In conclusion, functional H4 receptors increasing (35)S-GTPγS binding and/or decreasing noradrenaline release are not found in human, guinea pig and mouse cortex.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25300787     DOI: 10.1007/s00210-014-1053-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

Review 1.  Genomics meets histamine receptors: new subtypes, new receptors.

Authors:  L B Hough
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

Review 2.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

3.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

4.  Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  C Ballerini; A Aldinucci; I Luccarini; A Galante; C Manuelli; P Blandina; M Katebe; P L Chazot; E Masini; M B Passani
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability.

Authors:  G Desmadryl; S Gaboyard-Niay; A Brugeaud; C Travo; A Broussy; A Saleur; J Dyhrfjeld-Johnsen; E Wersinger; C Chabbert
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 6.  Effects of cannabinoids on neurotransmission.

Authors:  B Szabo; E Schlicker
Journal:  Handb Exp Pharmacol       Date:  2005

7.  Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.

Authors:  Herman D Lim; Richard M van Rijn; Ping Ling; Remko A Bakker; Robin L Thurmond; Rob Leurs
Journal:  J Pharmacol Exp Ther       Date:  2005-06-09       Impact factor: 4.030

8.  Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

9.  The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS.

Authors:  W M Connelly; F C Shenton; N Lethbridge; R Leurs; H J Waldvogel; R L M Faull; G Lees; P L Chazot
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

10.  Molecular determinants of ligand binding to H4R species variants.

Authors:  Herman D Lim; Chris de Graaf; Wen Jiang; Payman Sadek; Patricia M McGovern; Enade P Istyastono; Remko A Bakker; Iwan J P de Esch; Robin L Thurmond; Rob Leurs
Journal:  Mol Pharmacol       Date:  2010-01-26       Impact factor: 4.436

View more
  5 in total

1.  Histamine H4-receptor expression in the brain?

Authors:  Erich H Schneider; Detlef Neumann; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-26       Impact factor: 3.000

Review 2.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 3.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

4.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 5.  Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases.

Authors:  Pakhuri Mehta; Przemysław Miszta; Przemysław Rzodkiewicz; Olga Michalak; Piotr Krzeczyński; Sławomir Filipek
Journal:  Life (Basel)       Date:  2020-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.